SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT financial statements, including revenue, expenses, profit, and loss
The total revenue of 900904 for the last quarter is 62.19 M USD, and it's 15.20% lower compared to the previous quarter. The net income of Q3 24 is 3.00 M USD.